Civic AI
Procurement intelligence
Federal contract award
MONOCLONAL ANTIBODIES AND VIRAL RECOMBINANT ANTIGENS
MAPP BIOPHARMACEUTICAL, INC. · Department of Defense
- Value
- $110,500
- Start
- Jun 6, 2025
- End
- Dec 4, 2025
- Action date
- Jan 22, 2026
- PIID
- HT942525F0237
- Status
- completed
- NAICS
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- Place of performance
- SAN DIEGO, CA
- Award type
- DELIVERY ORDER
Description
MONOCLONAL ANTIBODIES AND VIRAL RECOMBINANT ANTIGENS
Need modifications, related awards, and vendor peers? Open the full award workspace.